Skip to main content
Log in

Genomic Characterization of Two NDM-5-Producing Isolates of Klebsiella pneumoniae ST11 from a Single Patient

  • Short Communication
  • Published:
Current Microbiology Aims and scope Submit manuscript

Abstract

Two metallo-β-lactamase-producing Klebsiella pneumoniae (HA30 and HA31) were isolated in a hospital in Argentina during 2018. K. pneumoniae HA30 was isolated from a rectal swab during the epidemiological surveillance for carbapenemase-producing strains, while K. pneumoniae HA31 was collected from the same patient 4 days after hospitalization. The aim of the present study was to identify the clonal relationships and resistome of these two NDM-producing K. pneumoniae strains isolated from a patient with a fatal outcome. Whole-genome sequencing (WGS) was performed using Illumina MiSeq-I, and subsequent analysis involved genome assembly, annotation, antibiotic resistance gene identification, multilocus sequence typing (MLST), and plasmid characterization using bioinformatics tools. Conjugation assays to E. coli J53 was conducted as previously described. K. pneumoniae HA30 exhibited extensively drug-resistant phenotype, while HA31 was multidrug-resistant as defined by Magiorakos et al., including both resistance to carbapenems, aminoglycosides and ciprofloxacin with blaNDM-5, blaCTX-M-15 and rmtB genes found in both strains. MLST analysis showed that both strains belonged to ST11, differing by only 4 cgSNPs, indicating that K. pneumoniae HA30 and HA31 were the same strain. Conjugation assays revealed that K. pneumoniae HA31 strain possessed a transferable plasmid to E. coli J53. Bioinformatics studies identified that the same strain colonizing an inpatient during hospital admission subsequently caused the infection leading to a fatal outcome, being the first report of blaNDM-5, rmtB and blaCTX-M-15 genes in a K. pneumoniae ST11 strain from Latin America. Our results also highlighted the importance of focusing on epidemiological surveillance programs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Liao W, Liu Y, Zhang W (2020) Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist 23:174–180

    Article  PubMed  Google Scholar 

  2. Cejas D, Magariños F, Elena A et al (2022) Emergence and clonal expansion of Klebsiella pneumoniae ST307, simultaneously producing KPC-3 and NDM-1. Rev Argent Microbiol. https://doi.org/10.1016/j.ram.2022.04.002

    Article  PubMed  Google Scholar 

  3. Magiorakos A-P, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x

    Article  PubMed  CAS  Google Scholar 

  4. Kong Y, Sun Q, Chen H et al (2021) Transmission dynamics of Carbapenem-Resistant Klebsiella pneumoniae sequence type 11 strains carrying capsular loci KL64 and rmpA/rmpA2 genes. Front Microbiol. https://doi.org/10.3389/fmicb.2021.736896

    Article  PubMed  PubMed Central  Google Scholar 

  5. Doi Y, Wachino J, Arakawa Y (2016) Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases. Infect Dis Clin N Am 30:523–537

    Article  Google Scholar 

  6. Bolourchi N, Shahcheraghi F, Giske CG et al (2021) Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals. Ann Clin Microbiol Antimicrob. https://doi.org/10.1186/s12941-021-00479-y

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by grant ISID/Pfizer 2019 given to DC, the grant PUE 2522 from CONICET given to IMPaM (UBA/CONICET), UBACYT Programación Científica 2018 given to DC and MPQ, PICT- 2021-I-INVI-00790 given to VEA, and PICT 2021 (1120) given to DC. DC and MPQ are members of the Carrera del Investigador Científico, CONICET, Argentina. NGA is an infectious diseases doctor. BF and LFC are clinical microbiology specialists. LCP is recipient of a CONICET doctoral fellowship. MP is recipient of an Universidad de Buenos Aires´s fellowship.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: DC; Methodology: VEÁ, LCP, MP, NGA, JC, BF and LF-C; Formal analysis and investigation: VEÁ, LCP, NM, AA, LF-C, MPQ and DC; Writing—original draft preparation: DC; Writing—review and editing: DC and VEÁ; Funding acquisition: DC, VEÁ and MPQ; Resources: DC and MPQ; Supervision: DC. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Daniela Centrón.

Ethics declarations

Conflict of interest

The authors declare there is no conflict of interest.

Ethical approval

Not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Álvarez, V.E., Carrera Páez, L., Piekar, M. et al. Genomic Characterization of Two NDM-5-Producing Isolates of Klebsiella pneumoniae ST11 from a Single Patient. Curr Microbiol 81, 76 (2024). https://doi.org/10.1007/s00284-023-03596-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00284-023-03596-3

Navigation